Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Costs of multiple sclerosis - extrapolation of Czech data to Polish patients.
An adverse lipid profile is associated with disability and progression in disability, in people with MS.
n-3 PUFAs Reduce T-Helper 17 Differentiation by Decreasing Responsiveness to Interleukin-6 in Isolated Splenic Mouse CD4+ T Cells.
The Combined Structural and Kinetic Characterization of a Bacterial Nitronate Monooxygenase from Pseudomonas aeruginosa PAO1 Establishes NMO Class I and II.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Development of a nanomaterial bio-screening platform for neurological applications.
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
Functionally Relevant White Matter Degradation in Multiple Sclerosis: A Tract-based Spatial Meta-Analysis.
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.
Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL.
The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
Time-Lapse Imaging of Glial-Axonal Interactions.
Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes.
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Multiple sclerosis and the blood-central nervous system barrier.
Peripheral blood mononuclear cell membrane fluidity and disease outcome in patients with multiple sclerosis.
Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
Gait variability and multiple sclerosis.
Structure-Kinetics Relationships - an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as CCR2 antagonists.
Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis.
A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility.
Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder.
[Mitoxantrone role in treatment of primary progressive multiple sclerosis].
Predicting degree of myelination based on diffusion tensor imagining of canines with mucopolysaccharidosis type I.
Pages
« first
‹ previous
…
391
392
393
394
395
396
397
398
399
…
next ›
last »